<DOC>
	<DOCNO>NCT00380315</DOCNO>
	<brief_summary>This study therapeutic confirmation AG1321001 evaluate safety efficacy anti-tussive agent cough patient .</brief_summary>
	<brief_title>Therapeutic Confirmatory Clinical Trial Evaluate Safety Efficacy AG1321001 Chronic Cougher</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<criteria>1 . Adult age 18 70 . 2 . Patient cough symptom cause following disease : chronic bronchitis , bronchiectasis , gastroesophageal reflux disease , postnasal drip syndrome cause rhinitis , sinusitis , rhinopharyngitis , rhinolaryngitis . 3 . Patient require internal treatment due cough symptom , cough 3 week . 4. patient continue cough 1 week . ( physician 's judgment ) 5 . Patient decide participate clinical trial ( ) agree write letter consent . 6 . Patient trustworthy , ready cooperation observe restriction trial period . 1 . Patient accompany seriously abnormal symptom respiratory system , Acute infectious Pulmonary Disease , Tuberculosis . 2 . Patient clinical history sensitivity Xanthine drug . 3 . Patient Peptic Ulcer Asthma ( Except Cicatrix ) 4 . Patient whose liver kidney function seriously abnormal : Including case sGOT , sGPT , bilirubin blood creatinine value exceed twice upper normal limit . 5 . Patient whose heart function abnormal : include case show abnormal EKG test value clinically significant . 6 . Patient experience participate clinical trial within two month start trial . 7 . Pregnant woman , lactate woman . 8. patient convulsion alcoholism . 9. patient take medicine use combination AG1321001 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Cough</keyword>
	<keyword>Chronic bronchitis</keyword>
	<keyword>PNDs</keyword>
	<keyword>Post Nasal Drip syndrome</keyword>
	<keyword>GERD</keyword>
	<keyword>gastroesophageal reflux disease</keyword>
	<keyword>bronchiectasis</keyword>
</DOC>